SLC16A1 and hepatocellular carcinoma: After treatment with ActD in macrophages, the prolonged half-life of SLC16A1 mRNA by HCC cell-derived exosomes was remarkably shortened by knockdown of HNRNPA1(Fig. 5J, K and Supplementary Fig. S4H).